DarioHealth Corp.

Company DRIO

Last mentioned: Mar 19, 2026

Stories mentioning DarioHealth Corp. 2

earnings Neutral

Biofrontera and DarioHealth Pivot Toward Profitability in Q4 2025 Results

Biofrontera and DarioHealth reported Q4 2025 results on March 19, 2026, highlighting a strategic shift from aggressive growth to sustainable profitability. While Biofrontera focuses on expanding its dermatology market share with Ameluz, DarioHealth is leveraging its B2B2C model to drive high-margin digital health revenue.

2 sources
pharma Neutral

Biofrontera and DarioHealth Signal Commercial Pivot in Q4 2025 Results

Biofrontera and DarioHealth reported Q4 2025 results that underscore a strategic shift toward high-margin clinical and enterprise markets. Both companies are prioritizing a path to profitability through disciplined cost management and the expansion of recurring revenue streams in dermatology and digital chronic care.

2 sources